These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 27699260)
1. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. Oon S; Huynh H; Tai TY; Ng M; Monaghan K; Biondo M; Vairo G; Maraskovsky E; Nash AD; Wicks IP; Wilson NJ JCI Insight; 2016 May; 1(6):e86131. PubMed ID: 27699260 [TBL] [Abstract][Full Text] [Related]
2. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus. Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y Front Immunol; 2018; 9():1957. PubMed ID: 30210502 [No Abstract] [Full Text] [Related]
3. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674 [TBL] [Abstract][Full Text] [Related]
4. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Savarese E; Chae OW; Trowitzsch S; Weber G; Kastner B; Akira S; Wagner H; Schmid RM; Bauer S; Krug A Blood; 2006 Apr; 107(8):3229-34. PubMed ID: 16368889 [TBL] [Abstract][Full Text] [Related]
5. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus. Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537 [TBL] [Abstract][Full Text] [Related]
7. CSL362 potently and specifically depletes pDCs Monaghan KA; Hoi A; Gamell C; Tai TY; Linggi B; Jordan J; Cesaroni M; Sato T; Ng M; Oon S; Benson J; Wicks I; Morand E; Wilson N iScience; 2023 Jul; 26(7):107173. PubMed ID: 37456846 [TBL] [Abstract][Full Text] [Related]
8. Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus. Jin O; Kavikondala S; Mok MY; Sun L; Gu J; Fu R; Chan A; Yeung J; Nie Y; Lau CS Arthritis Res Ther; 2010; 12(4):R137. PubMed ID: 20618924 [TBL] [Abstract][Full Text] [Related]
9. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus. Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389 [TBL] [Abstract][Full Text] [Related]
10. Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus Erythematosus. Jones JM; Smith F; Littlejohn E; Jorgensen TN Front Immunol; 2022; 13():888501. PubMed ID: 35833144 [TBL] [Abstract][Full Text] [Related]
11. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Guiducci C; Gong M; Xu Z; Gill M; Chaussabel D; Meeker T; Chan JH; Wright T; Punaro M; Bolland S; Soumelis V; Banchereau J; Coffman RL; Pascual V; Barrat FJ Nature; 2010 Jun; 465(7300):937-41. PubMed ID: 20559388 [TBL] [Abstract][Full Text] [Related]
12. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c Yim LY; Lau CS; Chan VS Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763 [TBL] [Abstract][Full Text] [Related]
13. Cutting Edge: BCAP Promotes Lupus-like Disease and TLR-Mediated Type I IFN Induction in Plasmacytoid Dendritic Cells. Chu T; Ni M; Chen C; Akilesh S; Hamerman JA J Immunol; 2019 May; 202(9):2529-2534. PubMed ID: 30936294 [TBL] [Abstract][Full Text] [Related]
14. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells. Dillmann C; Ringel C; Ringleb J; Mora J; Olesch C; Fink AF; Roberts E; Brüne B; Weigert A J Immunol; 2016 Feb; 196(4):1579-90. PubMed ID: 26783340 [TBL] [Abstract][Full Text] [Related]
15. Effect of Gardet A; Pellerin A; McCarl CA; Diwanji R; Wang W; Donaldson D; Franchimont N; Werth VP; Rabah D Front Immunol; 2019; 10():275. PubMed ID: 30846987 [No Abstract] [Full Text] [Related]
16. Neutralizing interferon-α blocks inflammation-mediated vascular injury via PI3K and AMPK in systemic lupus erythematosus. Ding X; Xiang W; Yi R; Huang X; Lin Q; He X Immunology; 2021 Oct; 164(2):372-385. PubMed ID: 34077562 [TBL] [Abstract][Full Text] [Related]
17. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes. Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814 [TBL] [Abstract][Full Text] [Related]